Literature DB >> 7624116

A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes.

K Yamato1, M Yamamoto, Y Hirano, N Tsuchida.   

Abstract

A human p53 mutant, p53Val-138 (amino acid 138, Alanine-->Valine), generated by in vitro mutagenesis was introduced into Saos-2 human osteosarcoma and Jurkat acute T-lymphoblastic leukemia cell lines, both lacking p53 protein expression. p53Val-138 caused growth arrest in Saos-2 cell line and apoptosis in Jurkat cell line at 32.5 degrees C while it allowed both cell lines to grow continuously at 37.5 degrees C. p53Val-138 activated expression of p53-responsive genes including MDM2, GADD45 and WAF1/CIP1/SD11 in Saos-2 cell line upon the temperature shift-down from 37.5 degrees C to 32.5 degrees C. Thus, p53Val-138 acted as a temperature-sensitive p53 mutant. Taking advantage of these human cell systems, we demonstrated that p53-mediated cell cycle arrest occurred in G1 and G2/M phases of Saos-2 cell line but not in Jurkat cell line. The induced level of WAF1/CIP1/SDI1 mRNA by p53 was extremely lower in Jurkat cell line than that of Saos-2 cell line. However, MDM2 mRNA accumulated to the similar levels in these two cell lines. These results suggest that a factor(s) other than p53 may be involved in differential expression of WAF1/CIP1/SDI1 and MDM2 mRNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624116

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; S Iyer; H Boulares; M E Smulson
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

2.  p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.

Authors:  M I Sandri; R J Isaacs; W M Ongkeko; A L Harris; I D Hickson; M Broggini; F Vikhanskaya
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  Proteolysis by calpains: a possible contribution to degradation of p53.

Authors:  M Pariat; S Carillo; M Molinari; C Salvat; L Debüssche; L Bracco; J Milner; M Piechaczyk
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

4.  Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain.

Authors:  D Spengler; M Villalba; A Hoffmann; C Pantaloni; S Houssami; J Bockaert; L Journot
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

5.  Reversal of the temperature-shift-induced growth restriction of a temperature-sensitive simian virus 40 T-antigen-transformed human fibroblast cell line by treatment with retinoic acid.

Authors:  Y P Tsao; S F Li; S W Kuo; J C Liu; S L Chen
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

6.  Nicotinamide protects HCN2 cells from the free radical generating toxin, tertiary butylhydroperoxide (t-BuOOH).

Authors:  Manisha Sonee; Johanna R. Martens; Suman K. Mukherjee
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 7.  Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins.

Authors:  F Hoppe-Seyler; K Butz
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

8.  The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cell-cycle progression and apoptosis induction of human leukemia cells.

Authors:  Carmela Fimognari; Michael Nüsse; Renato Iori; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

9.  Temperature sensitivity of human wild-type and mutant p53 proteins expressed in vivo.

Authors:  F Ponchel; J Milner
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

10.  Hypothermia Effectively Treats Tumors with Temperature-Sensitive p53 Mutations.

Authors:  Junhao Lu; Lihong Chen; Zheng Song; Mousumi Das; Jiandong Chen
Journal:  Cancer Res       Date:  2021-03-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.